Cancer medications and a treatment for a rare genetic disease have been added to Australia's Pharmaceutical Benefits Scheme.
The newly-listed drugs are used for patients with skin cancer, lung cancer and X-linked hypophosphatemia, a disorder which impacts bones and growth.
